Wei‐Bing Zhou

LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR‐200c‐3p to upregulate ANLN

Min Zhang, Feng Wang, Zhenxian Xiang et al. · Clinical and Experimental Pharmacology and Physiology · 2020 · 74 citations

Medicine, Oncology, Pharmacology +16

STARD4 promotes breast cancer cell malignancy

Min Zhang, Zhenxian Xiang, Feng Wang et al. · Oncology Reports · 2020 · 21 citations · Full text

Medicine, Cell Biology, Oncology +17

RIG‐I promotes IFN/JAK2 expression and the endoplasmic reticulum stress response to inhibit chemoradiation resistance in nasopharyngeal carcinoma

Di Jing, Wei‐Bing Zhou, Lin Shen et al. · Cancer Medicine · 2019 · 20 citations · Full text

Medicine, Immunology, Oncology +16

<p>ANLN Directly Interacts with RhoA to Promote Doxorubicin Resistance in Breast Cancer Cells</p>

Feng Wang, Zhen Xiang, Teng Huang et al. · Cancer Management and Research · 2020 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

Comprehensive characterization of stemness-related lncRNAs in triple-negative breast cancer identified a novel prognostic signature related to treatment outcomes, immune landscape analysis and therapeutic guidance: a silico analysis with in vivo experiments

Min Zhang, Fangxu Zhang, Jianfeng Wang et al. · Journal of Translational Medicine · 2024 · 19 citations · Full text

Life Sciences, Bioinformatics, Oncology +17